These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1298 related articles for article (PubMed ID: 21310164)

  • 1. Therapeutic significance of NR2B-containing NMDA receptors and mGluR5 metabotropic glutamate receptors in mediating the synaptotoxic effects of β-amyloid oligomers on long-term potentiation (LTP) in murine hippocampal slices.
    Rammes G; Hasenjäger A; Sroka-Saidi K; Deussing JM; Parsons CG
    Neuropharmacology; 2011 May; 60(6):982-90. PubMed ID: 21310164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The NMDA receptor antagonist Radiprodil reverses the synaptotoxic effects of different amyloid-beta (Aβ) species on long-term potentiation (LTP).
    Rammes G; Seeser F; Mattusch K; Zhu K; Haas L; Kummer M; Heneka M; Herms J; Parsons CG
    Neuropharmacology; 2018 Sep; 140():184-192. PubMed ID: 30016667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Block of long-term potentiation by naturally secreted and synthetic amyloid beta-peptide in hippocampal slices is mediated via activation of the kinases c-Jun N-terminal kinase, cyclin-dependent kinase 5, and p38 mitogen-activated protein kinase as well as metabotropic glutamate receptor type 5.
    Wang Q; Walsh DM; Rowan MJ; Selkoe DJ; Anwyl R
    J Neurosci; 2004 Mar; 24(13):3370-8. PubMed ID: 15056716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRZ-99030 - A novel modulator of Aβ aggregation: II - Reversal of Aβ oligomer-induced deficits in long-term potentiation (LTP) and cognitive performance in rats and mice.
    Rammes G; Gravius A; Ruitenberg M; Wegener N; Chambon C; Sroka-Saidi K; Jeggo R; Staniaszek L; Spanswick D; O'Hare E; Palmer P; Kim EM; Bywalez W; Egger V; Parsons CG
    Neuropharmacology; 2015 May; 92():170-82. PubMed ID: 25637092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for involvement of group II/III metabotropic glutamate receptors in NMDA receptor-independent long-term potentiation in area CA1 of rat hippocampus.
    Grover LM; Yan C
    J Neurophysiol; 1999 Dec; 82(6):2956-69. PubMed ID: 10601432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of GluN2B subunit containing N-methyl-d-aspartate (NMDA) receptors in mediating the acute and chronic synaptotoxic effects of oligomeric amyloid-beta (Aβ) in murine models of Alzheimer's disease (AD).
    Rammes G; Mattusch C; Wulff M; Seeser F; Kreuzer M; Zhu K; Deussing JM; Herms J; Parsons CG
    Neuropharmacology; 2017 Sep; 123():100-115. PubMed ID: 28174113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The metabotropic glutamate receptor 5 is necessary for late-phase long-term potentiation in the hippocampal CA1 region.
    Francesconi W; Cammalleri M; Sanna PP
    Brain Res; 2004 Oct; 1022(1-2):12-8. PubMed ID: 15353208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late phase of long-term potentiation induced by co-application of N-methyl-d-aspartic acid and the antagonist of NR2B-containing N-methyl-d-aspartic acid receptors in rat hippocampus.
    Oh-Nishi A; Saji M; Satoh SZ; Ogata M; Suzuki N
    Neuroscience; 2009 Mar; 159(1):127-35. PubMed ID: 19010396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble Aβ oligomers inhibit long-term potentiation through a mechanism involving excessive activation of extrasynaptic NR2B-containing NMDA receptors.
    Li S; Jin M; Koeglsperger T; Shepardson NE; Shankar GM; Selkoe DJ
    J Neurosci; 2011 May; 31(18):6627-38. PubMed ID: 21543591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orexin A induces bidirectional modulation of synaptic plasticity: Inhibiting long-term potentiation and preventing depotentiation.
    Lu GL; Lee CH; Chiou LC
    Neuropharmacology; 2016 Aug; 107():168-180. PubMed ID: 26965217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective subunit antagonists suggest an inhibitory relationship between NR2B and NR2A-subunit containing N-methyl-D: -aspartate receptors in hippocampal slices.
    Mallon AP; Auberson YP; Stone TW
    Exp Brain Res; 2005 Apr; 162(3):374-83. PubMed ID: 15580338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term potentiation in the nucleus accumbens requires both NR2A- and NR2B-containing N-methyl-D-aspartate receptors.
    Schotanus SM; Chergui K
    Eur J Neurosci; 2008 Apr; 27(8):1957-64. PubMed ID: 18412616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective induction of metabotropic glutamate receptor 1- and metabotropic glutamate receptor 5-dependent chemical long-term potentiation at oriens/alveus interneuron synapses of mouse hippocampus.
    Le Vasseur M; Ran I; Lacaille JC
    Neuroscience; 2008 Jan; 151(1):28-42. PubMed ID: 18035501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-methyl-D-aspartate receptor-dependent long-term potentiation in CA1 region affects synaptic expression of glutamate receptor subunits and associated proteins in the whole hippocampus.
    Zhong WX; Dong ZF; Tian M; Cao J; Xu L; Luo JH
    Neuroscience; 2006 Sep; 141(3):1399-413. PubMed ID: 16766131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Aβ aggregation modulator MRZ-99030 prevents and even reverses synaptotoxic effects of Aβ
    Rammes G; Parsons CG
    Neuropharmacology; 2020 Nov; 179():108267. PubMed ID: 32758564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NMDA receptor regulation by amyloid-beta does not account for its inhibition of LTP in rat hippocampus.
    Raymond CR; Ireland DR; Abraham WC
    Brain Res; 2003 Apr; 968(2):263-72. PubMed ID: 12663096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pramlintide Antagonizes Beta Amyloid (Aβ)- and Human Amylin-Induced Depression of Hippocampal Long-Term Potentiation.
    Kimura R; MacTavish D; Yang J; Westaway D; Jhamandas JH
    Mol Neurobiol; 2017 Jan; 54(1):748-754. PubMed ID: 26768593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The anaesthetic xenon partially restores an amyloid beta-induced impairment in murine hippocampal synaptic plasticity.
    Bürge M; Kratzer S; Mattusch C; Hofmann C; Kreuzer M; Parsons CG; Rammes G
    Neuropharmacology; 2019 Jun; 151():21-32. PubMed ID: 30940537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered GluN2B NMDA receptor function and synaptic plasticity during early pathology in the PS2APP mouse model of Alzheimer's disease.
    Hanson JE; Pare JF; Deng L; Smith Y; Zhou Q
    Neurobiol Dis; 2015 Feb; 74():254-62. PubMed ID: 25484285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Xenon attenuates hippocampal long-term potentiation by diminishing synaptic and extrasynaptic N-methyl-D-aspartate receptor currents.
    Kratzer S; Mattusch C; Kochs E; Eder M; Haseneder R; Rammes G
    Anesthesiology; 2012 Mar; 116(3):673-82. PubMed ID: 22293720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 65.